Literature DB >> 14534431

Identification and distribution of aspartoacylase in the postnatal rat brain.

Matthias Klugmann1, C Wymond Symes, Bettina K Klaussner, Claudia B Leichtlein, Tadao Serikawa, Deborah Young, Matthew J During.   

Abstract

Aspartoacylase metabolizes N-acetylaspartic acid to produce L-aspartate and acetate. An aspartoacylase deficiency in humans is responsible for Canavan disease, a lethal autosomal recessive leukodystrophy. The role of aspartoacylase in the mammalian brain is unclear. Here we have generated and characterized a highly specific polyclonal antibody against aspartoacylase which recognizes a 37 kDa monomer and a dimer in normal but not in aspartoacylase-deficient rat tissue. Aspartoacylase protein expression sharply increases at P14, peaks at P28 and plateaus thereafter. Biochemical analysis reveals immunoreactivity in cytosolic but not in membrane fractions. Histologically, most abundant expression was observed in white matter tracts and thalamus. On the cellular level, aspartoacylase immunoreactivity is restricted to oligodendrocyte somata in both white and gray matter.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534431     DOI: 10.1097/00001756-200310060-00016

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  16 in total

1.  Nuclear-cytoplasmic localization of acetyl coenzyme a synthetase-1 in the rat brain.

Authors:  Prasanth S Ariyannur; John R Moffett; Chikkathur N Madhavarao; Peethambaran Arun; Nisha Vishnu; David M Jacobowitz; William C Hallows; John M Denu; Aryan M A Namboodiri
Journal:  J Comp Neurol       Date:  2010-08-01       Impact factor: 3.215

Review 2.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

Review 3.  A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.

Authors:  Caroline D Rae
Journal:  Neurochem Res       Date:  2013-11-21       Impact factor: 3.996

4.  Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease.

Authors:  Peethambaran Arun; Chikkathur N Madhavarao; John R Moffett; Kristen Hamilton; Neil E Grunberg; Prasanth S Ariyannur; William A Gahl; Yair Anikster; Steven Mog; William C Hallows; John M Denu; Aryan M A Namboodiri
Journal:  J Inherit Metab Dis       Date:  2010-05-13       Impact factor: 4.982

5.  Characterization of human aspartoacylase: the brain enzyme responsible for Canavan disease.

Authors:  Johanne Le Coq; Hyun-Joo An; Carlito Lebrilla; Ronald E Viola
Journal:  Biochemistry       Date:  2006-05-09       Impact factor: 3.162

6.  Extensive aspartoacylase expression in the rat central nervous system.

Authors:  John R Moffett; Peethambaran Arun; Prasanth S Ariyannur; James Y Garbern; David M Jacobowitz; Aryan M A Namboodiri
Journal:  Glia       Date:  2011-05-19       Impact factor: 7.452

7.  Making the White Matter Matters: Progress in Understanding Canavan's Disease and Therapeutic Interventions Through Eight Decades.

Authors:  Seemin S Ahmed; Guangping Gao
Journal:  JIMD Rep       Date:  2015-01-21

8.  Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination.

Authors:  Natalia S Mattan; Cristina A Ghiani; Marcia Lloyd; Reuben Matalon; Dean Bok; Patrizia Casaccia; Jean de Vellis
Journal:  Neurobiol Dis       Date:  2010-07-14       Impact factor: 5.996

9.  Are astrocytes the missing link between lack of brain aspartoacylase activity and the spongiform leukodystrophy in Canavan disease?

Authors:  Morris H Baslow; David N Guilfoyle
Journal:  Neurochem Res       Date:  2009-03-25       Impact factor: 3.996

10.  Glyceryl triacetate for Canavan disease: a low-dose trial in infants and evaluation of a higher dose for toxicity in the tremor rat model.

Authors:  C N Madhavarao; P Arun; Y Anikster; S R Mog; O Staretz-Chacham; J R Moffett; N E Grunberg; W A Gahl; A M A Namboodiri
Journal:  J Inherit Metab Dis       Date:  2009-08-15       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.